Clobazam (marketed under the brand names Frisium, Urbanol, Onfi, and Tapclob ) is a benzodiazepine class medication that was patented in 1968 and has been marketed as an anxiolytic since 1975 and an anticonvulsant since 1984.
This report contains market size and forecasts of Clobazam in global, including the following market information:
Global Clobazam Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Clobazam Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Clobazam companies in 2021 (%)
The global Clobazam market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
10mg/Pcs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Clobazam include Lupin Pharmaceuticals, ROSEMONT Pharma, Amneal, Merck KGaA, Breckenridge Pharmaceutical, Upsher-Smith and Hikma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clobazam manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clobazam Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Clobazam Market Segment Percentages, by Type, 2021 (%)
10mg/Pcs
20mg/Pcs
Global Clobazam Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Clobazam Market Segment Percentages, by Application, 2021 (%)
Adults
Geriatric
Children
Global Clobazam Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Clobazam Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clobazam revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Clobazam revenues share in global market, 2021 (%)
Key companies Clobazam sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Clobazam sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lupin Pharmaceuticals
ROSEMONT Pharma
Amneal
Merck KGaA
Breckenridge Pharmaceutical
Upsher-Smith
Hikma